Potter Wz

457 total citations
18 papers, 387 citations indexed

About

Potter Wz is a scholar working on Pharmacology, Cellular and Molecular Neuroscience and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Potter Wz has authored 18 papers receiving a total of 387 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pharmacology, 3 papers in Cellular and Molecular Neuroscience and 3 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Potter Wz's work include Treatment of Major Depression (5 papers), Tryptophan and brain disorders (2 papers) and Pharmacological Effects and Toxicity Studies (2 papers). Potter Wz is often cited by papers focused on Treatment of Major Depression (5 papers), Tryptophan and brain disorders (2 papers) and Pharmacological Effects and Toxicity Studies (2 papers). Potter Wz collaborates with scholars based in United States and Czechia. Potter Wz's co-authors include Goodwin Fk, John Hsiao, M. Linnoila, Farouk Karoum, Irl Extein, Mika Scheinin, Michael S. Gold, Matthew V. Rudorfer, Markku Linnoila and Giovanni Muscettola and has published in prestigious journals such as PubMed and Munich Personal RePEc Archive (Ludwig Maximilian University of Munich).

In The Last Decade

Potter Wz

18 papers receiving 343 citations

Peers

Potter Wz
Comparison fields: 5 of 74
  • Psychiatry and Mental health 187
  • Pharmacology 123
  • Cellular and Molecular Neuroscience 107
  • Molecular Biology 58
  • Clinical Psychology 48
Replace Klerman Gl with:
Klerman Gl United States
Josef Schöpf Switzerland
Odd Lingjærde Norway
Jerry Oliver United States
Christian Geretsegger Austria
D.R. Thomas United Kingdom
M. Tannhauser Brazil
I Maany United States
John Scott Carman United States
T. A. Ban United States
Klerman Gl United States View profile →
Citations per field, relative to Potter Wz
Potter Wz · 1×
Citations per year, relative to Potter Wz
Potter Wz · 1×

Countries citing papers authored by Potter Wz

Since Specialization
Citations

This map shows the geographic impact of Potter Wz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Potter Wz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Potter Wz more than expected).

Fields of papers citing papers by Potter Wz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Potter Wz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Potter Wz. The network helps show where Potter Wz may publish in the future.

Co-authorship network of co-authors of Potter Wz

This figure shows the co-authorship network connecting the top 25 collaborators of Potter Wz. A scholar is included among the top collaborators of Potter Wz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Potter Wz. Potter Wz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
# Work Indexed citations
1
Acute alpha 2 blockade by idazoxan increases insulin and lowers plasma glucose during positron emission tomography.
5
2
Regulation of signal transduction pathways by mood-stabilizing agents: implications for the delayed onset of therapeutic efficacy.
58
3
Adrenoceptors and serotonin receptor function: relevance to antidepressant mechanisms of action.
34
4
International Psychopharmacology Algorithm Project Report.
35
5
Valproate and mood disorders: perspectives. Introduction.
2
6
Dosage regimen design for cyclic antidepressants: a review of pharmacokinetic methods.
6
7
Gender differences in pharmacokinetics and pharmacodynamics of psychotropics: focus on women.
38
8
ECT alters human monoamines in a different manner from that of antidepressant drugs.
11
9
CSF, plasma, and urine: what do concomitant measurements of norepinephrine and its metabolites mean?
11
10
Active metabolites of antidepressants: pharmacodynamics and relevant pharmacokinetics.
22
11
Effects of chronic desipramine on plasma norepinephrine concentrations and cardiovascular parameters in elderly depressed women: a preliminary report.
11
12
Reduction of norepinephrine turnover by serotonergic drug in man.
27
13
Temporal association between depression-dependent dyskinesias and high urinary phenylethylamine output.
8
14
Plasma haloperidol levels and clinical response in acute schizophrenia.
27
15
High positive correlation between urinary free tyramine excretion rate and "whole body" norepinephrine turnover in depressed patients.
14
16
Crossover study of zimelidine and desipramine in depression: evidence for amine specificity [proceedings].
8
17
Hydroxylated metabolites of tricyclic antidepressants: preclinical assessment of activity.
65
18
Prediction of steady state plasma concentration of imipramine [proceedings].
5

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026